Skip to main content
Erschienen in: Endocrine 1/2017

04.08.2017 | Research Letter

Association of fetuin-A to adiponectin ratio with metabolic syndrome: a cross-sectional study

verfasst von: Huixiang Ju, Zhongwei Zhou, Mingzhong Sun, Hongmei Chen

Erschienen in: Endocrine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

Fetuin-A is a protein which is an endogenous inhibitor inhibiting insulin receptor tyrosine kinase causing insulin resistance [1]. Increased fetuin-A expression has also been shown to be involved in excessive fat accumulation, impaired glucose tolerance and inflammatory processes [2, 3]. In the past years, a large body of research has demonstrated a strong positive correlation between increased fetuin-A levels and metabolic syndrome (MS) and its components [4, 5]. In contrast to fetuin-A, adiponectin is a protein with protective features against MS which is recognized as a critical regulator of insulin resistance, systemic inflammation, and glucose and lipid metabolism [6, 7]. A recent study revealed reduced circulating adiponectin levels are associated with the MS independently of obesity, lipid indices and serum insulin levels [8]. …
Literatur
1.
Zurück zum Zitat P.R. Srinivas, A.S. Wagner, L.V. Reddy, D.D. Deutsch, M.A. Leon, A.S. Goustin, G. Grunberger, Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol. Endocrinol. 7, 1445–1455 (1993)PubMed P.R. Srinivas, A.S. Wagner, L.V. Reddy, D.D. Deutsch, M.A. Leon, A.S. Goustin, G. Grunberger, Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol. Endocrinol. 7, 1445–1455 (1993)PubMed
2.
Zurück zum Zitat N. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, S.M. Krober, F. Machicao, A. Fritsche, H.U. Haring, Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29, 853–857 (2006)CrossRefPubMed N. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, S.M. Krober, F. Machicao, A. Fritsche, H.U. Haring, Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29, 853–857 (2006)CrossRefPubMed
3.
Zurück zum Zitat H.Y. Ou, Y.C. Yang, H.T. Wu, J.S. Wu, F.H. Lu, C.J. Chang, Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J. Clin. Endocrinol. Metab. 97, 4717–4723 (2012)CrossRefPubMed H.Y. Ou, Y.C. Yang, H.T. Wu, J.S. Wu, F.H. Lu, C.J. Chang, Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. J. Clin. Endocrinol. Metab. 97, 4717–4723 (2012)CrossRefPubMed
4.
Zurück zum Zitat J.H. Ix, M.G. Shlipak, V.M. Brandenburg, S. Ali, M. Ketteler, M.A. Whooley, Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113, 1760–1767 (2006)CrossRefPubMedPubMedCentral J.H. Ix, M.G. Shlipak, V.M. Brandenburg, S. Ali, M. Ketteler, M.A. Whooley, Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113, 1760–1767 (2006)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Y. Xu, M. Xu, Y. Bi, A. Song, Y. Huang, Y. Liu, Y. Wu, Y. Chen, W. Wang, X. Li, G. Ning, Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese. Atherosclerosis 216, 180–186 (2011)CrossRefPubMed Y. Xu, M. Xu, Y. Bi, A. Song, Y. Huang, Y. Liu, Y. Wu, Y. Chen, W. Wang, X. Li, G. Ning, Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese. Atherosclerosis 216, 180–186 (2011)CrossRefPubMed
6.
Zurück zum Zitat C. Tao, A. Sifuentes, W.L. Holland, Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic beta cells and adipocytes. Best Pract. Res. 28, 43–58 (2014)CrossRef C. Tao, A. Sifuentes, W.L. Holland, Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic beta cells and adipocytes. Best Pract. Res. 28, 43–58 (2014)CrossRef
7.
Zurück zum Zitat M. Esfahani, A. Movahedian, M. Baranchi, M.T. Goodarzi, Adiponectin: an adipokine with protective features against metabolic syndrome. Iran. J. Basic Med Sci. 18, 430–442 (2015)PubMedPubMedCentral M. Esfahani, A. Movahedian, M. Baranchi, M.T. Goodarzi, Adiponectin: an adipokine with protective features against metabolic syndrome. Iran. J. Basic Med Sci. 18, 430–442 (2015)PubMedPubMedCentral
8.
Zurück zum Zitat A. Ntzouvani, E. Fragopoulou, D. Panagiotakos, C. Pitsavos, S. Antonopoulou, Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study. Lipids Health Dis. 15, 140 (2016)CrossRefPubMedPubMedCentral A. Ntzouvani, E. Fragopoulou, D. Panagiotakos, C. Pitsavos, S. Antonopoulou, Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study. Lipids Health Dis. 15, 140 (2016)CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat N. Vionnet, E.H. Hani, S. Dupont, S. Gallina, S. Francke, S. Dotte, F. De Matos, E. Durand, F. Lepretre, C. Lecoeur, P. Gallina, L. Zekiri, C. Dina, P. Froguel, Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67, 1470–1480 (2000)CrossRefPubMedPubMedCentral N. Vionnet, E.H. Hani, S. Dupont, S. Gallina, S. Francke, S. Dotte, F. De Matos, E. Durand, F. Lepretre, C. Lecoeur, P. Gallina, L. Zekiri, C. Dina, P. Froguel, Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am. J. Hum. Genet. 67, 1470–1480 (2000)CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Z.W. Zhou, H.X. Ju, M.Z. Sun, Q.P. Fu, H.M. Chen, H.B. Ji, F. Ji, D.M. Jiang, Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy. Clin. Chim. Acta 455, 113–117 (2016)CrossRefPubMed Z.W. Zhou, H.X. Ju, M.Z. Sun, Q.P. Fu, H.M. Chen, H.B. Ji, F. Ji, D.M. Jiang, Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy. Clin. Chim. Acta 455, 113–117 (2016)CrossRefPubMed
11.
Zurück zum Zitat S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, C. Fernando, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive Summary. Crit. Pathw. Cardiol. 4, 198–203 (2005)CrossRefPubMed S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr., J.A. Spertus, C. Fernando, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive Summary. Crit. Pathw. Cardiol. 4, 198–203 (2005)CrossRefPubMed
12.
Zurück zum Zitat J.F. Trepanowski, J. Mey, K.A. Varady, Fetuin-A: a novel link between obesity and related complications. Int. J. Obes. 39, 734–741 (2015)CrossRef J.F. Trepanowski, J. Mey, K.A. Varady, Fetuin-A: a novel link between obesity and related complications. Int. J. Obes. 39, 734–741 (2015)CrossRef
13.
Zurück zum Zitat X. Lin, H.D. Braymer, G.A. Bray, D.A. York, Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. Life Sci. 63, 145–153 (1998)CrossRefPubMed X. Lin, H.D. Braymer, G.A. Bray, D.A. York, Differential expression of insulin receptor tyrosine kinase inhibitor (fetuin) gene in a model of diet-induced obesity. Life Sci. 63, 145–153 (1998)CrossRefPubMed
14.
Zurück zum Zitat S.T. Mathews, G.P. Singh, M. Ranalletta, V.J. Cintron, X. Qiang, A.S. Goustin, K.L. Jen, M.J. Charron, W. Jahnen-Dechent, G. Grunberger, Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51, 2450–2458 (2002)CrossRefPubMed S.T. Mathews, G.P. Singh, M. Ranalletta, V.J. Cintron, X. Qiang, A.S. Goustin, K.L. Jen, M.J. Charron, W. Jahnen-Dechent, G. Grunberger, Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51, 2450–2458 (2002)CrossRefPubMed
15.
Zurück zum Zitat N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, R. Komuro, N. Ouchi, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi, Y. Matsuzawa, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731–737 (2002)CrossRefPubMed N. Maeda, I. Shimomura, K. Kishida, H. Nishizawa, M. Matsuda, H. Nagaretani, N. Furuyama, H. Kondo, M. Takahashi, Y. Arita, R. Komuro, N. Ouchi, S. Kihara, Y. Tochino, K. Okutomi, M. Horie, S. Takeda, T. Aoyama, T. Funahashi, Y. Matsuzawa, Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8, 731–737 (2002)CrossRefPubMed
16.
Zurück zum Zitat N. Kubota, Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, W. Yano, P. Froguel, R. Nagai, S. Kimura, T. Kadowaki, T. Noda, Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277, 25863–25866 (2002)CrossRefPubMed N. Kubota, Y. Terauchi, T. Yamauchi, T. Kubota, M. Moroi, J. Matsui, K. Eto, T. Yamashita, J. Kamon, H. Satoh, W. Yano, P. Froguel, R. Nagai, S. Kimura, T. Kadowaki, T. Noda, Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277, 25863–25866 (2002)CrossRefPubMed
17.
Zurück zum Zitat Q. Liu, B. Yuan, K.A. Lo, H.C. Patterson, Y. Sun, H.F. Lodish, Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism. Proc. Natl Acad. Sci. USA 109, 14568–14573 (2012)CrossRefPubMedPubMedCentral Q. Liu, B. Yuan, K.A. Lo, H.C. Patterson, Y. Sun, H.F. Lodish, Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism. Proc. Natl Acad. Sci. USA 109, 14568–14573 (2012)CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat A.M. Hennige, H. Staiger, C. Wicke, F. Machicao, A. Fritsche, H.U. Haring, N. Stefan, Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 3, e1765 (2008)CrossRefPubMedPubMedCentral A.M. Hennige, H. Staiger, C. Wicke, F. Machicao, A. Fritsche, H.U. Haring, N. Stefan, Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One 3, e1765 (2008)CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat T.W. Jung, B.S. Youn, H.Y. Choi, S.Y. Lee, H.C. Hong, S.J. Yang, H.J. Yoo, B.H. Kim, S.H. Baik, K.M. Choi, Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A. Biochem. Pharmacol. 86, 960–969 (2013)CrossRefPubMed T.W. Jung, B.S. Youn, H.Y. Choi, S.Y. Lee, H.C. Hong, S.J. Yang, H.J. Yoo, B.H. Kim, S.H. Baik, K.M. Choi, Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A. Biochem. Pharmacol. 86, 960–969 (2013)CrossRefPubMed
Metadaten
Titel
Association of fetuin-A to adiponectin ratio with metabolic syndrome: a cross-sectional study
verfasst von
Huixiang Ju
Zhongwei Zhou
Mingzhong Sun
Hongmei Chen
Publikationsdatum
04.08.2017
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1383-5

Weitere Artikel der Ausgabe 1/2017

Endocrine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.